Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial
Bornstein, S. R., de Zeeuw, D., Heerspink, H. J. L., Schulze, F., Cronin, L., Wenz, A., Tuttle, K. R., Hadjadj, S. & Rossing, P., 18 mar. 2024, (E-pub ahead of print) I: Diabetes, Obesity and Metabolism.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review